Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03891602 · ClinicalTrials.gov registry record
DECIDE: Developing Tools for Lung Cancer Screening Discussion Improvement
A clinical trial, sponsored by Hackensack Meridian Health.
- Completed
- Registry status
- 654
- Enrollment target
NCT03891602: Completed study, sponsored by Hackensack Meridian Health.
NCT03891602 is a clinical trial that has completed, run by Hackensack Meridian Health. The registered enrollment target is 654 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03891602 has completed, sponsored by Hackensack Meridian Health.
- COMPLETED
- Registry status
- 654 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about discussion between clinicians and their patients related to lung screening. Survey answers will be collected from both clinicians and their patients.
Primary Outcome
Decisional Quality was measured using the multidimensional Decisional Conflict Scale, a 16-item Likert-response scale that was modified by the investigators for the lung cancer screening context. The total score ranging from 0 to 64. This total score is commonly transformed into a standardized score that falls within a 0 to 100 range. Decisional quality measured on this numeric scale from which lower scores represent lower decisional conflict and, therefore, higher decisional quality. Scores bel
Interventions
- BEHAVIORAL Cataldo Lung Cancer Stigma Scale (Smoking-Related Subscale)
- BEHAVIORAL Patient Trust in the Medical
- BEHAVIORAL Decision Conflict Scale (DCS) - Lung Cancer Screening
- BEHAVIORAL Shared Decision Making Questionnaire (SDM-Q)- Patient
- BEHAVIORAL Stage of Readiness for Smoking Cessation - Contemplation Ladder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 654 participants |
| Start Date | 2019-03-22 |
| Est. Completion | 2023-01-10 |
What the finished NCT03891602 record still lists
NCT03891602 is an observational study that tracks outcomes without assigning an intervention. The registered 654 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which Cataldo Lung Cancer Stigma Scale (Smoking-Related Subscale) is the first listed.
NCT03891602 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03891602 about?
NCT03891602 is a clinical study titled "DECIDE: Developing Tools for Lung Cancer Screening Discussion Improvement". The purpose of this study is to learn about discussion between clinicians and their patients related to lung screening. Survey answers will be collected from both clinicians and their patients.
What is the current status of trial NCT03891602?
This trial is currently completed. The enrollment target is 654 participants. The study started on 2019-03-22. Estimated completion is 2023-01-10.
What interventions are being tested in trial NCT03891602?
The interventions under investigation include: Cataldo Lung Cancer Stigma Scale (Smoking-Related Subscale) (BEHAVIORAL), Patient Trust in the Medical (BEHAVIORAL), Decision Conflict Scale (DCS) - Lung Cancer Screening (BEHAVIORAL), Shared Decision Making Questionnaire (SDM-Q)- Patient (BEHAVIORAL), Stage of Readiness for Smoking Cessation - Contemplation Ladder (BEHAVIORAL).
Who is sponsoring clinical trial NCT03891602?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07145515 · 655 participants · NA
Enhancing Heart Allograft Function With the OCS Heart System Trial
- NCT05407129 · 656 participants · NA
Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences
- NCT06127199 · 656 participants · NA
Contraceptive Efficacy Study of Ovaprene
- NCT06287346 · 652 participants
5-Years PMCF Study of Ceramic Dental Implants One-piece Versus Two-piece.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI